Stockreport

Axovant Announces Corporate Updates and Financial Results for Second Fiscal Quarter Ended September 30, 2019

Axovant Gene Therapies Ltd.  (AXGT) 
Last axovant gene therapies ltd. earnings: 2/10 06:00 am Check Earnings Report
PDF First evidence of clinical stabilization in two children with Tay-Sachs disease that received AXO-AAV-GM2 presented at ESGCT in October 2019Continued enrollment of patie [Read more]